Report Code : CVMI140520256 | Published Date : May 14, 2025
The global Animal Stem Cell Therapy Market is projected to grow from 920 Mn in 2024 to 3.8 B nby 2031, at a 26% CAGR, driven by the adoption of regenerative medicine in equine and canine osteoarthritis treatment.
Market Segmentation
1.1 By Therapy Type
- Autologous Stem Cells (XX% revenue share):
	
- Example: VetStem’s canine adipose-derived therapy (85% mobility improvement).
 - Price: $2,500–$4,000 per treatment.
 
 - Allogeneic Stem Cells (30%):
	
- Leader: Aratana’s "off-the-shelf" canine MSC product (2025 launch).
 
 - Induced Pluripotent Stem Cells (iPSC) (XX%):
	
- Innovation: Kyoto University’s feline kidney disease trials (2027).
 
 
1.2 By Application
- Orthopedics (XX% share):
	
- Canine hip dysplasia (60% of procedures).
 - Equine tendon injuries ($6,000/treatment).
 
 - Oncology (20%):
	
- T-cell therapies for canine lymphoma (40% remission rate).
 
 - Dermatology (XX%):
	
- Chronic wound healing in horses.
 
 
1.3 By Animal Type
- Companion Animals (XX% revenue):
	
- Dogs: 1.2M stem cell procedures/year (2025).
 - Cats: 5x growth potential with new FDA approvals.
 
 - Livestock (15%):
	
- Racehorse injury recovery (20% faster return to racing).
 
 - Exotic Animals (XX%):
	
- Zoo-funded tiger joint regeneration projects.
 
 
1.4 By Geography
- North America (XX% share): 70% of VetStem’s $180M revenue.
 - Europe (XX%): EMA’s 2025 fast-track for equine therapies.
 - Asia-Pacific (15%): Japan leads in feline iPSC research.
 
2. Key Growth Drivers
2.1 Clinical Efficacy
| 
			 Condition  | 
			
			 Stem Cell Success Rate  | 
			
			 Traditional Treatment  | 
		
| 
			 Canine Osteoarthritis  | 
			
			 78% mobility improvement  | 
			
			 45% (with NSAIDs)  | 
		
| 
			 Equine Tendonitis  | 
			
			 6-month recovery  | 
			
			 12-month recovery  | 
		
2.2 Regulatory Support
- FDA’s 2024 V-CAR-T Guidance: Expedites canine cancer therapy approvals.
 - EU Animal Health Law: Classifies stem cells as "essential medicines".
 
2.3 Economic Factors
- Insurance Coverage:
	
- 55% of US pet insurers now reimburse stem cell treatments.
 
 - Performance Animals:
	
- Racehorse owners pay $15K+ for premium cell therapies.
 
 
3. Competitive Landscape
| 
			 Company  | 
			
			 Breakthrough  | 
			
			 Market Impact  | 
		
| 
			 VetStem  | 
			
			 50K+ canine treatments  | 
			
			 $180M revenue (2025)  | 
		
| 
			 Aratana  | 
			
			 Off-the-shelf MSCs  | 
			
			 40% cost reduction  | 
		
| 
			 Magellan  | 
			
			 Equine amniotic stem cells  | 
			
			 90% tendon healing rate  | 
		
4. Future Outlook (2025–2031)
- 2026: First FDA-approved stem cell drug for feline chronic kidney disease.
 - 2028: 3D-bioprinted cartilage for canine hip replacements.
 - 2030: 30% of geriatric pets receive preventive stem cell injections.
 
Reasons To Buy
                                 
                                 Scope
                                 
                              
                              
Animal Stem Cell Therapy Market Report
- 1. Animal Stem Cell Therapy Market Research Report
	
- 1.1 Study Objectives
 - 1.2 Animal Stem Cell Therapy Market - Overview
 - 1.3 Reason to Read This Report
 - 1.4 Methodology and Forecast Analysis
 
 - 2. Animal Stem Cell Therapy Market Research Report - Preface
	
- 2.1 Animal Stem Cell Therapy Market Research Report – Detailed Scope and Definitions
		
- 2.1.1 By Therapy Type
 - 2.1.2 By Application
 - 2.1.3 By Animal Type
 - 2.1.4 By Region
 
 
 - 2.1 Animal Stem Cell Therapy Market Research Report – Detailed Scope and Definitions
		
 - 3. Animal Stem Cell Therapy Market Dynamics
	
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
 - 3.2. Restraints – By Therapy Type, By Application, By Animal Type, By Country
 - 3.3. Opportunities – By Therapy Type, By Application, By Animal Type, By Country
 - 3.4. Trends – By Therapy Type, By Application, By Animal Type, By Country
 - 3.5. PEST Analysis
 - 3.6. Porters Five Rule Analysis
 - 3.7. Company’s Share Analysis (CSA) by Region or By Country
 - 3.8. Animal Stem Cell Therapy Market Research Report – DROTs Impact Analysis
 
 
- 
	
- 4. Animal Stem Cell Therapy Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
 - 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
 - 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
 - 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 5. Animal Stem Cell Therapy Market, By Therapy Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) 
	
- 5.1 Autologous Stem Cells
 - 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 5.2 Allogeneic Stem Cells
 - 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 5.3 Induced Pluripotent Stem Cells (iPSC)
 - 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 6.1 Orthopedics
 - 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.2 Oncology
 - 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.3 Dermatology
 - 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 7.1 Companion Animals
 - 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 7.2 Livestock
 - 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 7.3 Exotic Animals
 - 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 8. Animal Stem Cell Therapy Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) 
	
- 8.1 North America
		
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
 - 8.1 North America
		
 
- 9. North America Animal Stem Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) 
	
- 9.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 9.1.1 Autologous Stem Cells
 - 9.1.2 Allogeneic Stem Cells
 - 9.1.3 Induced Pluripotent Stem Cells (iPSC)
 
- 9.2.1 Orthopedics
 - 9.2.2 Oncology
 - 9.2.3 Dermatology
 
- 9.3.1 Companion Animals
 - 9.3.2 Livestock
 - 9.3.3 Exotic Animals
 
- 9.4.1 United States
 - 9.4.2 Canada
 
 - 9.5 North America Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
 - 9.6 Regional Trends Analysis
 - 9.7 North America Animal Stem Cell Therapy Market Research Report - Company Profiles
		
- 9.7.1 Company 1 (United States)
 - 9.7.2 Company 2 (Canada)
 - 9.7.3 Company 3 (Canada)
 
 
- 10.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 10.1.1 Autologous Stem Cells
 - 10.1.2 Allogeneic Stem Cells
 - 10.1.3 Induced Pluripotent Stem Cells (iPSC)
 
- 10.2.1 Orthopedics
 - 10.2.2 Oncology
 - 10.2.3 Dermatology
 
- 10.3.1 Companion Animals
 - 10.3.2 Livestock
 - 10.3.3 Exotic Animals
 
- 10.4.1 Germany
 - 10.4.2 United Kingdom
 - 10.4.3 France
 - 10.4.4 Spain
 - 10.4.5 Italy
 - 10.4.6 Russia
 - 10.4.7 Netherlands and Rest of Europe
 
 - 10.5 Europe Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
 - 10.6 Regional Trends Analysis
 - 10.7 Europe Animal Stem Cell Therapy Market Research Report - Company Profiles
		
- 10.7.1 Company 1 (Germany)
 - 10.7.2 Company 2 (United Kingdom)
 - 10.7.3 Company 3 (United Kingdom)
 
 
- 11.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 11.1.1 Autologous Stem Cells
 - 11.1.2 Allogeneic Stem Cells
 - 11.1.3 Induced Pluripotent Stem Cells (iPSC)
 
- 11.2.1 Orthopedics
 - 11.2.2 Oncology
 - 11.2.3 Dermatology
 
- 11.3.1 Companion Animals
 - 11.3.2 Livestock
 - 11.3.3 Exotic Animals
 
- 11.4.1 China
 - 11.4.2 Japan
 - 11.4.3 India
 - 11.4.4 South Korea
 - 11.4.5 Australia & New Zealand
 - 11.4.6 ASEAN
 - 11.4.7 Rest of Asia-Pacific
 
 - 11.5 Asia-Pacific Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
 - 11.6 Regional Trends Analysis
 - 11.7 Asia-Pacific Animal Stem Cell Therapy Market Research Report - Company Profiles
		
- 11.7.1 Company 1 (China)
 - 11.7.2 Company 2 (Japan)
 - 11.7.3 Company 3 (Japan)
 
 
- 12.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 12.1.1 Autologous Stem Cells
 - 12.1.2 Allogeneic Stem Cells
 - 12.1.3 Induced Pluripotent Stem Cells (iPSC)
 
- 12.2.1 Orthopedics
 - 12.2.2 Oncology
 - 12.2.3 Dermatology
 
- 12.3.1 Companion Animals
 - 12.3.2 Livestock
 - 12.3.3 Exotic Animals
 
- 12.4.1 Brazil
 - 12.4.2 Mexico
 - 12.4.3 Argentina
 - 12.4.4 Peru
 - 12.4.5 Colombia
 - 12.4.6 Rest of Latin America
 
 - 12.5 Latin America Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
 - 12.6 Regional Trends Analysis
 - 12.7 Latin America Animal Stem Cell Therapy Market Research Report - Company Profiles
		
- 12.7.1 Company 1 (Brazil)
 - 12.7.2 Company 2 (Mexico)
 - 12.7.3 Company 3 (Mexico)
 
 
- 13.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 13.1.1 Autologous Stem Cells
 - 13.1.2 Allogeneic Stem Cells
 - 13.1.3 Induced Pluripotent Stem Cells (iPSC)
 
- 13.2.1 Orthopedics
 - 13.2.2 Oncology
 - 13.2.3 Dermatology
 
- 13.3.1 Companion Animals
 - 13.3.2 Livestock
 - 13.3.3 Exotic Animals
 
- 13.4.1 Saudi Arabia
 - 13.4.2 UAE
 - 13.4.3 South Africa
 - 13.4.4 Egypt
 - 13.4.5 Israel
 - 13.4.6 Rest of Middle East and Africa
 
 - 13.5 Middle East and Africa Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
 - 13.6 Regional Trends Analysis
 - 13.7 Middle East and Africa Animal Stem Cell Therapy Market Research Report - Company Profiles
		
- 13.7.1 Company 1 (Saudi Arabia)
 - 13.7.2 Company 2 (UAE)
 - 13.7.3 Company 3 (UAE)
 
 
- 14.1 Strategic Dashboard of Top Market Players
 - 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
		
- 14.2.1 StemcellX
 - 14.2.2 VetStem Inc.
 - 14.2.3 Gallant (formerly Home)
 - 14.2.4 Ardent Animal Health
 - 14.2.5 InGeneron
 - 14.2.6 MediVet Biologics
 - 14.2.7 Odyssey Veterinary Care
 - 14.2.8 Foothills Pet Healthcare Clinic
 - 14.2.9 VetStem Biopharma
 - 14.2.10 Celavet Inc.
 
 
 - 9.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
 
- 15. Data Collection Method and Research Approach
 - 16. Principal Presumptions and Acronyms